CNO Financial Group's 2Q25 Earnings: Navigating Through Numbers

By Your Favorite Financial Writer

Carmel, Indiana-based CNO Financial Group, Inc. (NYSE: CNO) reported its second-quarter earnings for 2025, and the numbers are in. The company declared a net income of $91.8 million, translating to an EPS of $0.91. While this is a dip from the $116.3 million, or $1.06 per diluted share, recorded in the same quarter last year, it’s not exactly a financial tragedy. Non-economic accounting impacts tied to market volatility played a role in both quarters, and it's worth noting that the company’s net operating income, which adjusts for those pesky non-economic factors, stood at $87.5 million, or $0.87 per diluted share, versus $114.6 million, or $1.05 per diluted share in 2Q24.

What’s Behind the Numbers?

CEO Gary C. Bhojwani articulated that CNO remains on track with its ambitious return on equity (ROE) targets for 2025-2027. This optimism is supported by the company's consistent revenue generation, showcasing a robust sales momentum that has lasted for twelve consecutive quarters. With operating earnings per share up 6% year-to-date, CNO appears to be navigating the choppy waters of the insurance sector with a steady hand.

Highlights from the Quarter

Several key metrics stand out from the earnings release:

Total new annualized premiums (NAP) increased by 17%, with Life NAP up 22% and Health NAP up 11%.
The Consumer Division NAP rose by 17%, while the Worksite Division saw a 16% increase. Clearly, CNO is not just treading water; it’s swimming with the current.
Collected premiums from annuities surged 19%, and client assets in brokerage and advisory services climbed by an impressive 27%.
In terms of shareholder returns, CNO delivered $116.7 million back to investors, proving that while earnings may fluctuate, their commitment to rewarding shareholders remains steadfast.
Book value per share hit $25.92, with book value per diluted share (excluding accumulated other comprehensive loss) increasing by 6% to $38.05.
Lastly, the ROE stands at a commendable 11.9%, with an operating ROE of 11.8%.

Looking Ahead

CNO’s ability to maintain its market share in the middle-income demographic is bolstered by its diverse product offerings and distribution channels. As the economic landscape shifts, the company seems well-prepared to adapt. The earnings surprise from this quarter, though not a showstopper, highlights a trajectory that is still on an upward path, even if slightly less steep than last year.

Investors should keep an eye on the company’s future performance, especially regarding the EPS consensus and any shifts in revenue forecasts as we move deeper into 2025. CNO’s strategic execution will be tested, but with a strong capital position and a focus on long-term growth, the company is in a decent spot to weather potential economic storms ahead.